Description | The formulation is from the literature DOI: 10.1002/adma.202303614. quaternary ammonium lipid-containing LNPs have better storage stability than conventional LNPs, as well as high transfection efficiency. The article indicates that AMB-POC18-LNPs is capable of spleen-specific mRNA transfection. |
Lipid composition | AMB-POC8/DOPE/OMG-PEG (50:20:0.5, mole ratio) |
Required fields are marked with *
×Product Name | Catalog | Lipid composition | Liposome Size | Price |
---|---|---|---|---|
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-008-L | Ionizable lipid/DOPE/Cholesterol/PEG-lipid (26.5:20:52:1.5, mole ratio) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-002-L | DOTAP/Cholesterol/DSPC/DSPE-PEG2000 (50:38.5:10:1.5, mole ratio) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-005-L | 4N4T lipids/DOPE/Chol/DMG-PEG2K (35:16:46.5:2.5, mole ratio) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-010-L | DPPC:MSPC:DSPE-PEG2000 (21.6:2.6:1.0, mole ratio) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-007-L | DLin-MC3-DMA/β-sitosterol/DMG-PEG2K/DSPC (50:36.5:3.5:10, mole ratio) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-014-L | DLin-MC3-DMA/DSPC/Cholesterol/DMG-PEG/Man-DSPE-PEG (50:10:38.5:0.5:1.0, mole ratio) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-009-L | DPPC:MSPC:DSPE-PEG2000 (86.5:9.7:3.8, mol %) | INQUIRY | |
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) | CDCLP24-011-L | AA3-DLin/DOPE/Cholesterol/DMG-PEG (40:40:25:0.5, molar ratio) | INQUIRY |
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.